Polymyalgia rheumatica (PMR) is an inflammatory disease that causes pain and stiffness in major muscle groups of your body, often including your neck, shoulders, and hip area. It’s the most ...

Corticosteroids are the mainstay of treatment for polymyalgia rheumatica, but there are other drug options, and physical activity can help, too. Polymyalgia Rheumatica Treatment: Medications ...

Polymyalgia rheumatica and giant cell arteritis PMR is closely linked with an autoimmune disease called giant cell arteritis (GCA), which is an inflammatory condition affecting the arteries.

Polymyalgia rheumatica is occasionally accompanied by sudden blindness ensuing upon relatively ... P. D. C., and McCallum, D. I. Skin manifestations of giant-cell arteritis. Brit. J. Dermal. 76: ...

BARCELONA, Spain — Compared with placebo, adding methotrexate (MTX) to treatment for newly diagnosed polymyalgia rheumatica (PMR) nearly doubled glucocorticoid (GC)-free remission rates at 1 ...

Both polymyalgia rheumatica (PMR) and rheumatoid arthritis (RA) are autoimmune conditions. They make your immune system attack your joints. These conditions have many similarities, but they have ...

ANSWER: Polymyalgia rheumatica (PMR) is not an uncommon disease, yet I find that many people haven’t heard of it. It’s a disease that is most common in people in their 70s, more common in ...

Sparrow Pharmaceuticals Expands Phase 2 Clinical Trial of SPI-62 with Prednisolone for Polymyalgia Rheumatica with ... sleeplessness, osteoporosis (bone loss), glaucoma, thinning of the skin, and ...

Scientists have found success in treating a 'neglected' inflammatory condition, polymyalgia rheumatica, with a drug that could provide an alternative to steroids for patients.

The FDA recently approved sarilumab (Kevzara) for the treatment of adults with polymyalgia rheumatica (PMR) who had an inadequate response to corticosteroids (CS) or are unable to tolerate a CS taper.

PHILADELPHIA — Treatment with the interleukin-6 receptor antagonist sarilumab (Kevzara), along with a 14-week taper of glucocorticoids, proved to have significant efficacy in patients with ...